Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 4 | +3.49M | 100% | $1.73 | +$6.03M |
Sells | 0 | ||||
Net | +4 | +3.49M | 100% | +$6.03M |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Peter A. Thompson | Director, 10%+ Owner | $14.5M | +$2.5M | +20.8% | Jun 13, 2024 |
Terry P. Gould | Director, 10%+ Owner | $5.67M | Jun 13, 2024 | ||
Richard A. Miller | President and CEO, Director | $3.06M | +$1M | +48.6% | Dec 20, 2024 |
Adams Street Partners Llc | 10%+ Owner | $2.59M | Aug 11, 2022 | ||
Orbimed Advisors Llc | Director, 10%+ Owner | $2.5M | +$2.5M | May 6, 2024 | |
William Benton Jones | SVP, Pharmaceutical Development | $266K | +$34.6K | +15% | Dec 20, 2024 |
EcoR1 Capital, LLC | 10%+ Owner | $64.1K | Sep 30, 2021 | ||
Linda Grais | Director | Jun 13, 2024 | |||
Scott W. Morrison | Director | Jun 13, 2024 | |||
Leiv Lea | Chief Financial Officer | Dec 20, 2024 | |||
Ian T. Clark | Director | Jun 13, 2024 | |||
Edith P. Mitchell | Director | Dec 6, 2023 | |||
Jeffrey Arcara | Chief Business Officer | Dec 20, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|